New Evidence of Significant Association between EBV Presence and Lymphoproliferative Disorders Susceptibility in Patients with Rheumatoid Arthritis: A Systematic Review with Meta-Analysis

Development of lymphoproliferative disorders (LPDs) is one of the well-known life-threatening complications in rheumatoid arthritis (RA) patients. However, there is a lack of definitive conclusions regarding the role of Epstein-Barr virus (EBV) activity in RA initiation and progression, especially i...

Full description

Bibliographic Details
Published in:	Viruses
Main Authors:	Ana Banko, Danijela Miljanovic, Ivana Lazarevic, Ivica Jeremic, Aleksa Despotovic, Milka Grk, Andja Cirkovic
Format:	Article
Language:	English
Published:	MDPI AG 2022-01-01
Subjects:	EBV rheumatoid arthritis lymphoproliferative disorders lymphoma meta-analysis
Online Access:	https://www.mdpi.com/1999-4915/14/1/115

Similar Items

Markers of Epstein–Barr Virus Infection in Association with the Onset and Poor Control of Rheumatoid Arthritis: A Prospective Cohort Study
by: Danijela Miljanovic, et al.
Published: (2023-07-01)

Uncovering the Role of Epstein–Barr Virus Infection Markers for Remission in Rheumatoid Arthritis
by: Ana Banko, et al.
Published: (2023-08-01)

EBV-RELATED LYMPHOPROLIFERATIVE DISEASES: A REVIEW IN LIGHT OF NEW CLASSIFICATIONS
by: Pietro Tralongo, et al.
Published: (2024-04-01)

Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus
by: Ana Banko, et al.
Published: (2023-12-01)

A rare case of three distinct Epstein-Barr virus associated lymphoproliferative disorders over sixteen years of human immunodeficiency virus infection
by: Hamdy M.A. Ahmed, et al.
Published: (2017-06-01)

Clonal heterogeneity of polymorphic B-cell lymphoproliferative disease, EBV-positive, iatrogenic/immune senescence: implications on pathogenesis and treatment
by: Yu-Yan Hwang, et al.
Published: (2022-12-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)

EBV-Associated Lymphoproliferative Disorders
by: Young Hyeh Ko
Published: (2021-04-01)

Leaky Artemis Deficiency and EBV‐Related Lymphoproliferative Disease: A Novel Case and Review of the Literature
by: Lucie Roussel, et al.
Published: (2025-04-01)

A Systematic Review of Epstein–Barr Virus Latent Membrane Protein 1 (LMP1) Gene Variants in Nasopharyngeal Carcinoma
by: Ana Banko, et al.
Published: (2021-08-01)

Treatment Advances in EBV Related Lymphoproliferative Diseases
by: Kebing Lv, et al.
Published: (2022-04-01)

CD137 deficiency because of two novel biallelic TNFRSF9 mutations in a patient presenting with severe EBV‐associated lymphoproliferative disease
by: Kefeng Shen, et al.
Published: (2023-01-01)

Protracted Tonsillitis as an Atypical Initial Manifestation of Methotrexate-Induced EBV-Positive Lymphoproliferative Disorder in Rheumatoid Arthritis: A Case Report and Literature Review
by: Ting-Shen Lin, et al.
Published: (2025-06-01)

Epstein-Barr Virus and Human Papillomavirus Coinfection in Colorectal Carcinoma: Systematic Review and Meta-Analysis of the Prevalence
by: Ana Banko, et al.
Published: (2024-10-01)

Navigating Epstein–Barr Virus (EBV) and Post-Transplant Lymphoproliferative Disorder (PTLD) in Pediatric Liver Transplantation: Current Knowledge and Strategies for Treatment and Surveillance
by: Erin Y. Chen, et al.
Published: (2025-02-01)

Systematic review with meta-analysis of active herpesvirus infections in patients with COVID-19: Old players on the new field
by: Ana Banko, et al.
Published: (2023-05-01)

The BCL‐2 family protein inhibitor ABT‐737 as an additional tool for the treatment of EBV‐associated post‐transplant lymphoproliferative disorders
by: Aude Robert, et al.
Published: (2020-10-01)

EBV-Positive Lymphoproliferative Diseases: A New Concept and Differential Diagnosis (Literature Review and Case Reports)
by: АM Kovrigina
Published: (2018-10-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
by: Daniela Capello, et al.
Published: (2009-11-01)

POST-TRANSPLANT LYMPHOPROLIFERATIVE DISORDERS: ROLE OF VIRAL INFECTION, GENETIC LESIONS AND ANTIGEN STIMULATION IN THE PATHOGENESIS OF THE DISEASE
by: Gianluca Gaidano, et al.
Published: (2009-11-01)

EBV AND HIV-RELATED LYMPHOMA
by: Michele Bibas, et al.
Published: (2009-12-01)

EBV AND HIV-RELATED LYMPHOMA
by: Andrea Antinori, et al.
Published: (2009-11-01)

Hemophagocytic lymphohistiocytosis syndrome secondary to systemic hydroa vacciniforme lymphoproliferative disorder: a case report and literature review
by: Sai YANG, et al.
Published: (2024-02-01)

Virus-specific T-cells from third party or transplant donors for treatment of EBV lymphoproliferative diseases arising post hematopoietic cell or solid organ transplantation
by: Richard J. O’Reilly, et al.
Published: (2024-01-01)

Age-related EBV-associated B-cell lymphoproliferative disorders of the minor salivary gland: a case report
by: Hiroyuki Makihara, DDS, et al.
Published: (2016-09-01)

EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria
by: Rana Habeeb, et al.
Published: (2021-12-01)

Case report: EBV-related eye orbits and sinuses lymphohistiocytic infiltration responsive to rituximab in a patient with X lymphoproliferative syndrome type 1
by: Giuliana Giardino, et al.
Published: (2024-04-01)

Macrophage activation syndrome triggered by methotrexate-related lymphoproliferative disease in a patient with rheumatoid arthritis
by: Hirotoshi Kato, et al.
Published: (2023-10-01)

Epstein–Barr Virus-Induced Post-Transplant Lymphoproliferative Disorder of the Central Nervous System Successfully Treated with Chemo-Immunotherapy
by: Hiroaki Inoue, et al.
Published: (2020-04-01)

Lymphoproliferative malignancies in patients with neurofibromatosis 1
by: Christina Bergqvist, et al.
Published: (2021-05-01)

Pulmonary comorbidity in chronic lymphoproliferative diseases: realities of the problem in the Dnipro region
by: K.Yu. Gashynova , et al.
Published: (2021-12-01)

Immunology of EBV-Related Lymphoproliferative Disease in HIV-Positive Individuals
by: Polina Shindiapina, et al.
Published: (2020-09-01)

Lymphoproliferative diseases in primary Sjogren's syndrome
by: V. i. Vasiljev, et al.
Published: (2022-11-01)

An exploratory study on the differential diagnostic indicators between adult systemic EBV-positive T-cell lymphoproliferative disorders and angioimmunoblastic T-cell lymphoma with multiple EBV infections
by: Xiaodan Zheng, et al.
Published: (2025-01-01)

Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes
by: Thomas Mika, et al.
Published: (2019-12-01)

Autoimmune Lymphoproliferative Syndrome in Children with Nonmalignant Organomegaly, Chronic Immune Cytopenia, and Newly Diagnosed Lymphoma
by: Zühre Kaya, et al.
Published: (2021-06-01)

Primary Cutaneous B-Cell Lymphomas in Patients With Impaired Immunity
by: Irene Russo, et al.
Published: (2020-09-01)

EBV-associated T-cell lymphoproliferative disorders of central nervous system
by: Feifei Wang, et al.
Published: (2025-03-01)

A unique case of a fulminant clonal CD8-positive T-cell lymphoproliferative disorder with CNS involvement
by: Lia Mesbah-Oskui, et al.
Published: (2023-09-01)

The Global Landscape of EBV-Associated Tumors
by: Claire Shannon-Lowe, et al.
Published: (2019-08-01)